GlassScriptPhysician profile
Jonathan S Appelbaum
NPI 1215975503
$58,536.00
in general payments reported to CMS, 2019-2025
9 companies · $165 in 2025
The $165 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $9,335 · 2021: $9,496 · 2022: $6,426 · 2023: $248 · 2024: $12K · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $895 · Travel and Lodging: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,305.00 |
| Food and Beverage | $894.61 |
| Travel and Lodging | $217.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $35,160.68 | 2019-2025 | Cabenuva, Apretude, Dovato |
| Emd Serono, INC. | $11,773.98 | 2024 | |
| Merck Sharp & Dohme LLC | $8,560.69 | 2019-2024 | Pifeltro, Delstrigo |
| Theratechnologies INC. | $2,279.28 | 2019-2024 | Egrifta, Trogarzo |
| Janssen Scientific Affairs, LLC | $501.00 | 2021 | |
| Janssen Products, LP | $166.54 | 2019-2023 | Symtuza |
| Pfizer INC. | $37.81 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.50 | 2022-2023 | |
| Novo Nordisk INC | $24.52 | 2024 | Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Appelbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.